Publications by authors named "Nathan Vandergrift"

Claim this Profile
I
Identifying compounds to treat opiate use disorder by leveraging multi-omic data integration and multiple drug repurposing databases.
Jeran K Stratford, Megan Ulmer Carnes, Caryn Willis, Melyssa S Minto, Logain Elnimeiry, Nathan Vandergrift

Transl Psychiatry· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial.
Jennifer L Brown, Marc R Larochelle, Laura C Fanucchi, Deirdre C Calvert, Aimee N C Campbell, Nathan Vandergrift

Drug Alcohol Depend· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial.
Louisa Gilbert, Rouba Chahine, Redonna Chandler, Daniel J Feaster, Erin Kim, Nathan Vandergrift

Int J Drug Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a pathogen X tabletop exercise to assess the operational response preparedness of an emerging infectious diseases research network.
Rachael Lee, Jennifer Hemingway-Foday, Nefer Batsuli, L Danielle Wagner, Aaron Macoubray, Nathan Vandergrift

Front Public Health· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Development and validation of a community-level social determinants of health index for drug overdose deaths in the HEALing Communities Study" [Journal of Substance Use and Addiction Treatment (2024) 209186].
Nina Cesare, Lisa M Lines, Redonna Chandler, Erin B Gibson, Rachel Vickers-Smith, Nathan Vandergrift

J Subst Use Addict Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study.
Ismene L Petrakis, Tracy Nolen, Nathan Vandergrift, Shawn Hirsch, John H Krystal

Am J Addict· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the Communities That HEAL Intervention on Overdose Education and Naloxone Distribution: A Cluster-Randomized, Wait-List Controlled Trial.
Patricia R Freeman, Alexander Y Walley, T John Winhusen, Emmanuel A Oga, Jennifer Villani, Nathan A Vandergrift

Am J Public Health· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.

N Engl J Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial.
LaShawn Glasgow, Christian Douglas, Joel G Sprunger, Aimee N C Campbell, Redonna Chandler, Nathan Vandergrift

Drug Alcohol Depend· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a community-level social determinants of health index for drug overdose deaths in the HEALing Communities Study.
Nina Cesare, Lisa M Lines, Redonna Chandler, Erin B Gibson, Rachel Vickers-Smith, Nathan Vandergrift

J Subst Use Addict Treat· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study.
Alissa Davis, Kristi Lynn Stringer, Mari-Lynn Drainoni, Carrie B Oser, Hannah K Knudsen, Nathan Vandergrift

Int J Drug Policy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbid alcohol use disorder and posttraumatic stress disorder: A proof-of-concept randomized placebo-controlled trial of buprenorphine and naltrexone combination treatment.
Lori L Davis, Ismene L Petrakis, Patricia D Pilkinton, Tracy Nolen, Nathan Vandergrift

Alcohol Clin Exp Res (Hoboken)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of model-based vs. permutation tests in the HEALing (Helping to End Addiction Long-term) Communities Study, a covariate-constrained cluster randomized trial.
Xiaoyu Tang, Timothy Heeren, Philip M Westgate, Daniel J Feaster, Soledad A Fernandez, Nathan Vandergrift

Trials· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument.
Raj S Kasthuri, Shruti Chaturvedi, Sonia Thomas, Nathan Vandergrift, Carla Bann

Blood Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marginal modeling in community randomized trials with rare events: Utilization of the negative binomial regression model.
Philip M Westgate, Debbie M Cheng, Daniel J Feaster, Soledad Fernández, Abigail B Shoben, Nathan Vandergrift

Clin Trials· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge.
Barbara K Felber, Zhongyan Lu, Xintao Hu, Antonio Valentin, Margherita Rosati, Nathan A Vandergrift

Cell Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization.
Qifeng Han, Todd Bradley, Wilton B Williams, Derek W Cain, David C Montefiori, Nathan A Vandergrift

Cell Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.
Cody S Nelson, Diana Vera Cruz, Melody Su, Guanhua Xie, Nathan Vandergrift

J Virol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys.
Jonathon E Himes, Ria Goswami, Riley J Mangan, Amit Kumar, Thomas L Jeffries, Nathan A Vandergrift

Mucosal Immunol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses.
Todd Bradley, Dimitra Peppa, Isabela Pedroza-Pacheco, Dapeng Li, Derek W Cain, Nathan A Vandergrift

Cell· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells.
Maria Blasi, Donatella Negri, Celia LaBranche, S Munir Alam, Erich J Baker, Nathan A Vandergrift

Commun Biol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
Cody S Nelson, Tori Huffman, Jennifer A Jenks, Eduardo Cisneros de la Rosa, Guanhua Xie, Nathan Vandergrift

Proc Natl Acad Sci U S A· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates.
Kevin O Saunders, Sampa Santra, Robert Parks, Nicole L Yates, Laura L Sutherland, Nathan Vandergrift

J Virol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys.
Quang N Nguyen, David R Martinez, Jonathon E Himes, R Whitney Edwards, Qifeng Han, Nathan Vandergrift

Retrovirology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational analysis of antibody dynamics identifies recent HIV-1 infection.
Kelly E Seaton, Nathan A Vandergrift, Aaron W Deal, Wes Rountree, John Bainbridge

JCI Insight· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis